FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula: (R2R3)-A1-c(A2-A3-A4-A5-A6-A7-A8-A9)-A10-R1, and pharmaceutically acceptable salts thereof, which act as ligands for one or more melanocortin receptors, methods of using said compounds to treat mammals and pharmaceutical compositions containing said compounds.
EFFECT: improved method.
29 cl, 8 dwg, 10 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MELANOCORTIN RECEPTOR LIGANDS | 2006 |
|
RU2380372C2 |
| LIGANDS OF MELANOCORTIN RECEPTORS | 2006 |
|
RU2401841C2 |
| APPLICATION OF MELANOCORTIN FOR TREATING INSULIN SENSITIVITY | 2008 |
|
RU2453328C2 |
| METHOD FOR TREATMENT OF DISORDERS ASSOCIATED WITH MELANOCORTIN 4 RECEPTOR PATH | 2016 |
|
RU2785889C1 |
| HYDANTOIN MODIFIED MELANOCORTIN RECEPTOR LIGANDS | 2008 |
|
RU2450017C2 |
| NEUROMEDIN AND SOMATOSTATIN RECEPTOR AGONISTS | 2000 |
|
RU2263680C2 |
| PEPTIDE COMPOSITIONS | 2014 |
|
RU2725150C2 |
| ALPHA- AND GAMMA-MSH ANALOGUES | 2013 |
|
RU2668791C2 |
| GLP-1 ANALOGUES | 1999 |
|
RU2208015C2 |
| PEPTIDE VECTORS | 2004 |
|
RU2361876C2 |
